Treating neurodegeneration by modifying mitochondria: potential solutions to a "complex" problem.
about
Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic interventionAlzheimer's disease pathologic cascades: who comes first, what drives whatThe role of mitochondria-derived reactive oxygen species in hyperthermia-induced platelet apoptosisCross talk between mitochondria and NADPH oxidasesHigh fat diet increases hippocampal oxidative stress and cognitive impairment in aged mice: implications for decreased Nrf2 signalingMitochondrial peptidase IMMP2L mutation causes early onset of age-associated disorders and impairs adult stem cell self-renewalMitochondrial dysfunction increases oxidative stress and decreases chronological life span in fission yeastThe Effect of Co0.2Mn0.8Fe2O4 Ferrite Nanoparticles on the C2 Canine Mastocytoma Cell Line and Adipose-Derived Mesenchymal Stromal Stem Cells (ASCs) Cultured Under a Static Magnetic Field: Possible Implications in the Treatment of Dog Mastocytoma.The Alzheimer's disease mitochondrial cascade hypothesisThe neurodegenerative mitochondriopathies.Age-related mitochondrial changes after traumatic brain injuryEffects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity.Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes.Mitochondrial Dysfunction and Oxidative Stress in Asthma: Implications for Mitochondria-Targeted Antioxidant TherapeuticsIslamic fasting and multiple sclerosis.Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies.Mitochondrial medicine for aging and neurodegenerative diseasesRole and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases.Alterations in mitochondrial number and function in Alzheimer's disease fibroblastsMitochondrial reactive oxygen species-mediated NLRP3 inflammasome activation contributes to aldosterone-induced renal tubular cells injury.Peroxisome Proliferator-Activated Receptor-gamma in Amyotrophic Lateral Sclerosis and Huntington's Disease.Therapeutically targeting mitochondrial redox signalling alleviates endothelial dysfunction in preeclampsiaThe Alzheimer's disease mitochondrial cascade hypothesis: an updateAmyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease.Mitochondria in mammalian sperm physiology and pathology: a review.Involvement of ROS in BBB dysfunction.Mitochondrial energy metabolism and redox signaling in brain aging and neurodegenerationAPP Deletion Accounts for Age-Dependent Changes in the Bioenergetic Metabolism and in Hyperphosphorylated CaMKII at Stimulated Hippocampal Presynaptic Active Zones.The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.Bioenergetic medicine.Targeting mitochondrial dysfunction in neurodegenerative disease: Part I.Sirtuins: from metabolic regulation to brain aging.Nicotinamide Adenine Dinucleotide Metabolism and Neurodegeneration.Bioenergetics and metabolism: a bench to bedside perspective.Mitochondria, Cybrids, Aging, and Alzheimer's Disease.Oxaloacetate activates brain mitochondrial biogenesis, enhances the insulin pathway, reduces inflammation and stimulates neurogenesis.Metabolic clues to salubrious longevity in the brain of the longest-lived rodent: the naked mole-rat.
P2860
Q26865358-1835ECCA-9784-4767-A322-B71CEFC2BF6FQ26995896-CD783B19-7F47-4678-80A9-52AB05C68186Q28388114-C883A95C-4317-402E-9C8C-8090738EE909Q28391403-2026B4D9-6425-4AE1-9CDD-678617A13595Q30496730-81E20CB0-79A8-480B-B9D0-CFF4425FA2B7Q30501000-295A5AB8-2A8D-4EFB-9D1C-FD6452202E68Q33356053-F4C9CC07-EB46-4C94-88C6-FCA5DD7E76B1Q33695224-A1F3FA17-CBC8-4854-8DA6-4CAAF0CE5412Q33905871-D280804D-C603-414D-AE73-3410FA4FE553Q33957065-C21B7143-2D04-4C00-83E4-52B9F104E0B7Q34147870-ED22878A-98C2-4D1C-B05B-354F78C5F469Q34228522-269F7F10-B735-41E9-9E0E-E285CC5789A1Q34552263-22F937B3-B35D-4021-81B2-9A504070CC5DQ34731547-545F9677-4E12-4C51-9117-A8F2A6B83653Q35127335-73537359-B897-4D92-BE94-FA1C07B6687CQ35140660-BFD53EE7-67E7-49BC-9379-D312A22501C4Q35606693-546FD559-16DE-46EE-B5D4-339A29A982C9Q35958359-79268376-E239-4724-AD86-D6FEE1C427A4Q36709696-2A64A1FB-B88A-4C86-8395-B929EDF77382Q37109510-FBB96664-BB11-4085-83E9-ED6453A0D3EBQ37157528-B3FE5DCD-7E27-4D78-AAA3-A28538ADB14DQ37239844-D292B969-9CF6-41B1-AC96-1ECD99167F96Q37261159-45D25065-C291-4E4B-8579-F7CB484D894AQ37261203-43BF2CB5-F2B8-46A4-99D0-EA165917D00BQ37368467-2A164794-16C4-4BEB-A42F-77D0F2B47EAEQ37400756-F0868156-2E54-416E-967E-E550F6C572EFQ37460232-F2984BCD-1B19-4282-AC7C-4F67DA5B1FEEQ37594982-6E49800D-6E6E-441B-B3FF-48A16E63FC79Q37656554-CEE86F38-D663-4335-BC88-097659B3AE94Q37686246-471FBB6C-9CC2-47C9-A9D7-AE5190E6CFA2Q37698597-BD6B5429-4AE2-4EB8-99F4-30C1C1BD7DDBQ38124259-20CA5EAC-79C9-424B-BE53-478C63E7C6F3Q38678550-F4713EDA-1E3E-41DA-8C47-0ECAA635B93EQ38770543-FF5E9F63-E359-4DBB-A1CD-4917C6D60C0AQ38932850-71823EDE-FFAC-44AF-9209-4D48EA9894B8Q42047971-0ADE8518-D5E4-4EF2-9DBB-7B2186CF5247Q46733752-E91118DF-7A84-48AE-9E5E-36F17D970F63
P2860
Treating neurodegeneration by modifying mitochondria: potential solutions to a "complex" problem.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Treating neurodegeneration by ...... utions to a "complex" problem.
@ast
Treating neurodegeneration by ...... utions to a "complex" problem.
@en
type
label
Treating neurodegeneration by ...... utions to a "complex" problem.
@ast
Treating neurodegeneration by ...... utions to a "complex" problem.
@en
prefLabel
Treating neurodegeneration by ...... utions to a "complex" problem.
@ast
Treating neurodegeneration by ...... utions to a "complex" problem.
@en
P356
P1476
Treating neurodegeneration by ...... utions to a "complex" problem.
@en
P2093
Russell H Swerdlow
P304
P356
10.1089/ARS.2007.1676
P577
2007-10-01T00:00:00Z